Clinical Trial Update: Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain [Phase 3]

View source ↗

Summary

A Phase 3 placebo-controlled study evaluating the safety and efficacy of pregabalin for post-traumatic peripheral neuropathic pain has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Post-traumatic Neuropathic Pain

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Neuropathic Pain | Phase 3 | Status: COMPLETED | Results posted: 2017-06-07